Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

9 resultsUpdated October 25, 2026
1

CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis

Clinics and Research in Hepatology and Gastroenterology 42(6) (2018)

Ye Zhou; Xuebin Wang; Xueping Qiu; Shuai Zhang; Chen Wang; Fang Zheng

3

Evaluation of Relationship between Occurrence of Liver Cancer and Methylation of Fragile Histidine Triad (FHIT) and P16 Genes

Medical Science Monitor 25 (2019)

Yu Bai; Yun-zhi Shen; Qiang Yuan; Chengyu Lv; Qianzhe Xing

4

Relation of the methylation state of RUNX3 and p16 gene promoters with hepatocellular carcinoma in Egyptian patients

Egyptian Journal of Medical Human Genetics 23(1) (2022)

Fatma F. El-shaarawy; Mai M. Abo ElAzm; Rasha H. Mohamed; Mohamed I. Radwan; Dina Mohamed Abo–Elmatty; Eman T. Mehanna

6

Aberrant p16 methylation as an early diagnostic marker in blood of hepatocellular carcinoma patients

Egyptian Journal of Medical Human Genetics 20(1) (2019)

Arig Aly Seif; Heba Hassan Aly; Doaa M A Elzoghby; Ashraf Mohammed Elbreedy; Mohamed Ahmed Lotfy

7

Aberrant p16INK4A methylation: Relation to viral related chronic liver disease and hepatocellular carcinoma

South Asian Journal of Cancer 03(01) (2014)

Fatma El‐Mougy; Mohammed Youssef; Dalia Omran; Sahar Abd El-Atty Sharaf; Hany H. El-Sayed; Walaa Ahmed Rabie; Elghobary A. Mohamed; Hany Elghobary

8

Prevalence of p16 Methylation and Prognostic Factors in Plasma Cell Myeloma at a Single Institution in Korea

Annals of Laboratory Medicine 33(1) (2012)

Hyun‐Jung Kim; Dong Wook Jekarl; Myungshin Kim; Yonggoo Kim; Jihyang Lim; Kyungja Han; Chang‐Ki Min